Esuprone
CAS No. 91406-11-0
Esuprone( —— )
Catalog No. M34246 CAS No. 91406-11-0
Esuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 193 | In Stock |
|
| 5MG | 205 | In Stock |
|
| 10MG | 302 | In Stock |
|
| 25MG | 489 | In Stock |
|
| 50MG | 695 | In Stock |
|
| 100MG | 977 | In Stock |
|
| 200MG | 1321 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEsuprone
-
NoteResearch use only, not for human use.
-
Brief DescriptionEsuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.
-
DescriptionEsuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorMAO
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91406-11-0
-
Formula Weight282.31
-
Molecular FormulaC13H14O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=2C(=CC(OS(CC)(=O)=O)=CC2)OC(=O)C1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PSB-1491
PSB-1491 is a selective and competitive monoamine oxidase B inhibitor with IC50 of 0.386 nM, >25000-fold selective versus MAO-A.
-
Ladostigil
Ladostigil (Ladostigil free base) is an orally active dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO) with inhibitory effects on MAO-B and AChE, with IC50 values of 37.1 and 31.8 μM, respectively.
-
hMAO-B-IN-5
hMAO-B-IN-5 is a potent reversible and selective human monoamine oxidase hMAO-B inhibitor (IC50:0.12μM).
Cart
sales@molnova.com